Login / Signup

Safety of Combined Targeted and Helixor ® Viscum album L. Therapy in Breast and Gynecological Cancer Patients, a Real-World Data Study.

Friedemann SchadAnja Thronicke
Published in: International journal of environmental research and public health (2023)
VA does not negatively alter the safety profile of targeted therapies in breast and gynaecological cancer patients.
Keyphrases
  • electronic health record
  • cancer therapy
  • big data
  • stem cells
  • machine learning
  • drug delivery
  • bone marrow